Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

InfectiousDiseases

Home » InfectiousDiseases
Current Challenges in Treating Gram-Positive Bacterial Infections: Insights from ECCMID 2023 Interview with Dr. José Luis Del Pozo

Current Challenges in Treating Gram-Positive Bacterial Infections: Insights from ECCMID 2023 Interview with Dr. José Luis Del Pozo

Posted by By Mourabit Halima 2024.01.15
Dr. José Luis Del Pozo The field of infectious diseases constantly evolves, presenting clinicians and researchers with new challenges. At the 33rd European Congress of Clinical Microbiology & Infectious…
Read More
IDWeek Interview | Dr. Shields: Real-World Study on the Efficacy of Two Generation BL-BLI Combination Therapy for MDR-PA

IDWeek Interview | Dr. Shields: Real-World Study on the Efficacy of Two Generation BL-BLI Combination Therapy for MDR-PA

Posted by By Peter W. PENG 2023.11.28
Editor's Note: Ceftolozane-tazobactam is a new BL-BLI combination drug, and ceftolozane is a third-generation cephalosporin antibiotic, and tazobactam is a beta-lactamase inhibitor. At the recent 2023 IDWeek in the United…
Read More
IDWeek Commentary | Dr. Yonghong Xiao: Intestinal colonization with MDRO, horizontal transmission and risk for bloodstream infection

IDWeek Commentary | Dr. Yonghong Xiao: Intestinal colonization with MDRO, horizontal transmission and risk for bloodstream infection

Posted by By Peter W. PENG 2023.11.27
Editor's Note: Bacterial drug resistance is a significant challenge in the global public health field. Multidrug-resistant organisms (MDROs), represented by carbapenem-resistant Enterobacteriaceae (CRE), carbapenem-resistant Acinetobacter baumannii (CRAB), carbapenem-resistant Pseudomonas aeruginosa…
Read More
Recent Posts
  • EBMT 2026 China Voice | Dr. Yishan Ye: Rethinking Donor Selection — Haploidentical Transplantation May Be the Optimal Choice for MRD-Positive AML
  • EBMT 2026 China Voice | Professor Xiaojun Huang: Haploidentical Hematopoietic Stem Cell Transplantation for Rare Diseases — Practice and Insights from the Beijing Protocol
  • EBMT 2026 China Voice | Professor Jia Wei: A Powerful Combination Strategy Reshaping the Tumor Microenvironment and Opening a New Era of Durable Benefit in CAR-T Therapy
  • EBMT 2026 China Voice | Professor Yuqian Sun: A New Strategy for Donor Selection in Elderly Haploidentical Transplantation — Younger Donors Are Better
  • ASCO GU Expert Insights | Professor Scott T. Tagawa: Transforming Prostate Cancer Care and the Future of Precision Therapy
Recent Comments
    Archives
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top